Interview
Innovation in Regulatory Science (CIRS) and BioWorld magazine. I am also responsible for the academic services team, covering data and consultancy delivery to academic institutions and governments. I have an incredible leadership team working with me. They deliver insight and perspective on developments in the company and the markets we serve. They challenge the status quo for Clarivate and the broader research community on a daily basis.
What does it mean to be the Geschäftsführer for Clarivate GmbH? It’s another word for managing director – I am the regional signatory in the corporate structure for Clarivate in Germany. It means I take care of regional operational affairs in the corporate matrix, supporting our central legal and finance teams.
What does ‘thought leadership’ mean to you? It is about understanding the status quo, and having the breadth and depth of knowledge, as well as the confidence to challenge it with new concepts and new ideas. Across Clarivate we are lucky to have thought leaders in the ISI, CIRS, and BioWorld, which have a very clear editorial
voice and produced the Drugs to Watch publications this year. Beyond those established platforms, we have thought leaders in every part of our organisation, resulting in ground-breaking new products, such as Publons and Kopernio.
What is the biggest challenge facing STM research and publishing? One of the biggest challenges facing not just the industry, but also society, is increasing scrutiny relating to the way public funds are spent, and how this is approached. The ramifications of decisions being made today will impact many generations to come and we have a shared responsibility to make sure there is fair, representative evaluation across all subject areas, and recognition across STM and into the social sciences is absolutely critical. The important role social sciences and the humanities play is all too often overshadowed by the dominant technical industries. But I am not sure any of us would want to experience a world where science, technology and medicine operate in the absence of ethics, robust political systems and policies. Policy makers, academics and publishers tackling the challenge of defining common success collaboratively is going to
be critical, if we are going to add long term, sustainable value to society for generations to come.
Lastly, what inspires you? I still feel every day that it is an absolute privilege to be entrusted with the work of researchers and academics – whether as publisher or now working in bibliometric indexing – to handle the work of the greatest minds of our generation is inspiring. In the hustle and bustle of office life, that can get lost, but it is what I always come back to. I feel great pride and responsibility in what we do. Specifically at Clarivate, the bibliometric metadata underpinning the Web of Science and other datasets that we are the guardians of, represent literally thousands of years of passion, ingenuity, intellect, excellence and academic perseverance. The academic and research community have the ability to speak truth to power, to influence governments, to protect the weak and influence society and culture. It is inspiring and humbling to play a small role in that landscape.
Interviews by Tim Gillett
nature.com
COLLABORATING TO ADDRESS THE KEY CONCERNS OF TODAY Nature Research Journals publishing from 2020
Nature Cancer
Nature Cancer will publish across the spectrum of the natural, applied and social sciences, from basic pre-clinical studies to translational and clinical work.
Nature Food
Nature Food will publish cutting edge research on all aspects of food production, processing, distribution and consumption that contribute to human and planetary health.
Nature Reviews Earth & Environment
Nature Reviews Earth & Environment will publish high quality Review, Perspective and Comment articles across all aspects of Earth and Environmental science.
For more information or to request a quote for your institution:
springernature.com/newlaunches2020
A77531
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36
